IDR 50.0
(0.0%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | 5.46 Billion IDR | -46.53% |
2022 | 10.22 Billion IDR | -61.3% |
2021 | 26.42 Billion IDR | -8.32% |
2020 | 28.82 Billion IDR | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q2 | 267.53 Million IDR | 106.44% |
2024 Q1 | 129.59 Million IDR | -97.05% |
2023 Q2 | -7.38 Billion IDR | -1113.44% |
2023 FY | 5.46 Billion IDR | -46.53% |
2023 Q1 | 729.05 Million IDR | 0.0% |
2022 FY | 10.22 Billion IDR | -61.3% |
2021 FY | 26.42 Billion IDR | -8.32% |
2020 FY | 28.82 Billion IDR | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
PT Mark Dynamics Indonesia Tbk | 156.01 Billion IDR | 96.495% |
PT Hetzer Medical Indonesia Tbk | -3.57 Billion IDR | 253.155% |
PT Jayamas Medica Industri Tbk | 259.35 Billion IDR | 97.892% |